AtriCure(us:ATRC)

32.26

+1.35%

Updated on 2025-03-31

Open:31.40
Close:32.26
High:32.54
Low:31.02
Prev Close:31.83
Volume:474585.00
Turnover:15.30M
Turnover Ratio:0.97%
Shares:48.88M
MarketCap:1.58B
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-3024250596794103.93%2597102
2024-03-3125649339243101.98%3483116
2023-12-312634711188199.13%39102103
2023-09-302434506680195.09%279295
2023-06-302404473141594.47%258891
2023-03-312364415304693.46%349078
2022-12-312374506766196.79%2774105
2022-09-302334434610995.48%248491
dateorgNametotalratiochangeShareschangeRatio
2024-06-30Vanguard Group Inc46219339.49%-131052-2.76%
2024-06-30Blackrock Inc.46157919.48%3847339.09%
2024-06-30Alliancebernstein L.P.42049798.64%55223815.12%
2024-06-30Champlain Investment Partners, Llc26749455.49%-6055-0.23%
2024-06-30Fmr Llc21123534.34%-364922-14.73%
2024-06-30Macquarie Group Ltd19980494.10%58482441.38%
2024-06-30First Light Asset Management, Llc19647034.04%58184342.08%
2024-06-30Hood River Capital Management Llc17752433.65%1775243
2024-06-30Wellington Management Group Llp15378513.16%-102311-6.24%
2024-06-30State Street Corp12818542.63%951818.02%

About

AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.
Address:7555 Innovation Way

Market Movers